Go Pro

Kewaunee Scientific (KEQU) Stock Price, News & Analysis

Kewaunee Scientific logo
$37.07 +0.60 (+1.65%)
As of 08/21/2026 04:00 PM Eastern

About Kewaunee Scientific Stock (NASDAQ:KEQU)

Advanced

Key Stats

Today's Range
$36.36
$37.07
50-Day Range
$34.00
$38.11
52-Week Range
$33.27
$60.89
Volume
5,360 shs
Average Volume
2,829 shs
Market Capitalization
$106.39 million
P/E Ratio
11.51
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia. Kewaunee Scientific’s project management and engineering teams collaborate with clients from initial concept and space planning through detailed design, fabrication and on-site installation. This end-to-end approach is designed to streamline lab construction, ensure compliance with safety and environmental regulations, and optimize workflow efficiency.

In addition to core furniture and containment products, Kewaunee offers specialized services including lab infrastructure assessments, commissioning, maintenance and lifecycle facility upgrades. Its offerings are tailored to sectors such as higher education, pharmaceutical research, biotechnology, petrochemicals and electronics manufacturing. The company’s focus on sustainability and ergonomics has led to the development of energy-efficient fume hoods and adaptable bench systems that meet evolving regulatory standards.

In early 2024, Kewaunee Scientific was acquired by Dover Corporation and now operates as part of Dover’s Safety and Productivity Solutions segment. Leveraging Dover’s global footprint and resources, Kewaunee continues to expand its market presence while maintaining its brand identity and commitment to innovation in laboratory design and engineering.

AI Generated. May Contain Errors.

Kewaunee Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

KEQU MarketRank™: 

Kewaunee Scientific scored higher than 28% of companies evaluated by MarketBeat, and ranked 818th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kewaunee Scientific has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Kewaunee Scientific has only been the subject of 1 research reports in the past 90 days.

  • Read more about Kewaunee Scientific's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Kewaunee Scientific is 11.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.45.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Kewaunee Scientific is 11.51, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.60.

  • Price to Book Value per Share Ratio

    Kewaunee Scientific has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Kewaunee Scientific's valuation and earnings.
  • Percentage of Shares Shorted

    1.93% of the float of Kewaunee Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Kewaunee Scientific has a short interest ratio ("days to cover") of 8.24.
  • Change versus previous month

    Short interest in Kewaunee Scientific has recently decreased by 1.54%, indicating that investor sentiment is improving.
  • Dividend Yield

    Kewaunee Scientific does not currently pay a dividend.

  • Dividend Growth

    Kewaunee Scientific does not have a long track record of dividend growth.

  • News Sentiment

    Kewaunee Scientific has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Kewaunee Scientific this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Kewaunee Scientific insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.10% of the stock of Kewaunee Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    32.69% of the stock of Kewaunee Scientific is held by institutions.

  • Read more about Kewaunee Scientific's insider trading history.
Receive KEQU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kewaunee Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KEQU Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Headlines

KEQU Stock Analysis - Frequently Asked Questions

Kewaunee Scientific's stock was trading at $37.41 at the beginning of 2026. Since then, KEQU stock has decreased by 0.9% and is now trading at $37.07.

Kewaunee Scientific Corporation (NASDAQ:KEQU) announced its quarterly earnings results on Tuesday, June, 23rd. The technology company reported $1.14 EPS for the quarter. The technology company had revenue of $71.40 million for the quarter. Kewaunee Scientific had a net margin of 3.41% and a trailing twelve-month return on equity of 14.10%.

Top institutional investors of Kewaunee Scientific include Punch & Associates Investment Management Inc. (3.68%), De Lisle Partners LLP (1.83%) and BlackRock Inc. (0.42%). Insiders that own company stock include Thomas David Hull III, John Russell, Keith M Gehl, Ryan S Noble, Donald T Gardner III, Elizabeth D Phillips and Douglas J Batdorff.
View institutional ownership trends
.

Shares of KEQU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kewaunee Scientific investors own include Broadcom (AVGO), NVIDIA (NVDA), e.l.f. Beauty (ELF), Jabil (JBL), Arista Networks (ANET), Adobe (ADBE) and Disc Medicine (IRON).

Company Calendar

Last Earnings
6/23/2026
Today
8/23/2026
AGM 2026
8/26/2026
Next Earnings (Estimated)
9/16/2026
Fiscal Year End
4/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:KEQU
CIK
55529
Employees
1,231
Year Founded
1906

Profitability

EPS (Trailing Twelve Months)
$3.22
Trailing P/E Ratio
11.51
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$9.62 million
Net Margins
3.41%
Pretax Margin
4.87%
Return on Equity
14.10%
Return on Assets
5.55%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.18
Quick Ratio
1.55

Sales & Book Value

Annual Sales
$282 million
Price / Sales
0.38
Cash Flow
$5.96 per share
Price / Cash Flow
6.22
Book Value
$26.80 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
2,870,000
Free Float
2,464,000
Market Cap
$106.39 million
Optionable
Not Optionable
Beta
0.72

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:KEQU) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners